Medifast, Inc is a personal services business based in the US. Medifast shares (MED) are listed on the NYSE and all prices are listed in US Dollars. Medifast employs 713 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Medifast
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MED – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Medifast stock price (NYSE: MED)Use our graph to track the performance of MED stocks over time.
Medifast shares at a glance
|Latest market close||$332.25|
|52-week range||$137.18 - $335.17|
|50-day moving average||$277.92|
|200-day moving average||$260.49|
|Wall St. target price||$356.67|
|Dividend yield||$4.81 (1.72%)|
|Earnings per share (TTM)||$10.57|
Buy Medifast shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Medifast stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Medifast price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||16.04%|
|3 months (2021-04-30)||46.31%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is Medifast under- or over-valued?
Valuing Medifast stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medifast's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medifast's P/E ratio
Medifast's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Medifast shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Medifast's PEG ratio
Medifast's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medifast's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medifast's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $172.1 million.
The EBITDA is a measure of a Medifast's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||15.01%|
|Gross profit TTM||$697.8 million|
|Return on assets TTM||38.94%|
|Return on equity TTM||8783.43%|
|Market capitalisation||$3.3 billion|
TTM: trailing 12 months
Shorting Medifast shares
There are currently 391,804 Medifast shares held short by investors – that's known as Medifast's "short interest". This figure is 22.9% up from 318,903 last month.
There are a few different ways that this level of interest in shorting Medifast shares can be evaluated.
Medifast's "short interest ratio" (SIR)
Medifast's "short interest ratio" (SIR) is the quantity of Medifast shares currently shorted divided by the average quantity of Medifast shares traded daily (recently around 97706.733167082). Medifast's SIR currently stands at 4.01. In other words for every 100,000 Medifast shares traded daily on the market, roughly 4010 shares are currently held short.
However Medifast's short interest can also be evaluated against the total number of Medifast shares, or, against the total number of tradable Medifast shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medifast's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Medifast shares in existence, roughly 30 shares are currently held short) or 0.0378% of the tradable shares (for every 100,000 tradable Medifast shares, roughly 38 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medifast.
Find out more about how you can short Medifast stock.
Medifast share dividends
Dividend payout ratio: 58.49% of net profits
Recently Medifast has paid out, on average, around 58.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medifast shareholders could enjoy a 2.02% return on their shares, in the form of dividend payments. In Medifast's case, that would currently equate to about $4.81 per share.
Medifast's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Medifast's most recent dividend payout was on 5 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 20 June 2021 (the "ex-dividend date").
Medifast share price volatility
Over the last 12 months, Medifast's shares have ranged in value from as little as $137.181 up to $335.1738. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medifast's is 1.444. This would suggest that Medifast's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medifast, Inc. , through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and its franchisee system. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. .
Stocks similar to Medifast
Medifast in the news
Dividend Challenger Highlights: Week Of August 1
Medifast (MED) Queued for Q2 Earnings: Key Things to Note
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Frequently asked questionsWhat percentage of Medifast is owned by insiders or institutions?
Currently 4.414% of Medifast shares are held by insiders and 85.156% by institutions. How many people work for Medifast?
Latest data suggests 713 work at Medifast. When does the fiscal year end for Medifast?
Medifast's fiscal year ends in December. Where is Medifast based?
Medifast's address is: 100 International Drive, Baltimore, MD, United States, 21202 What is Medifast's ISIN number?
Medifast's international securities identification number is: US58470H1014 What is Medifast's CUSIP number?
Medifast's Committee on Uniform Securities Identification Procedures number is: 42221F101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert